View in EDS

Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial.

Saved in:
Bibliographic Details
Title: Neoadjuvant chemoradiation for patients with resectable locally advanced oral cavity squamous cell carcinoma: Results of the prospective INVERT clinical trial.
Authors: Fleischmann M; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany. Electronic address: Maximilian.Fleischmann@unimedizin-ffm.de., Kristen A; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany., Winkelmann R; Senckenberg Institute of Pathology, Goethe-University Frankfurt, Frankfurt, Germany., Burck I; Department of Diagnostic and Interventional Radiology, Goethe-University Frankfurt, Frankfurt, Germany., Weigert A; Institute of Biochemistry I, Faculty of Medicine, Goethe-University Frankfurt, Frankfurt, Germany., Issing C; Department of Otorhinolaryngology, Goethe-University Frankfurt, Frankfurt, Germany., Diefenhardt M; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Martin D; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Brandts C; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany., Rödel F; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Balermpas P; Department of Medicine, Hematology/Oncology, Goethe-University Frankfurt, Frankfurt, Germany., von der Grün J; Department of Radiation Oncology, University Hospital Zurich, Zurich, Switzerland., Thönissen P; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany., Rödel C; Department of Radiotherapy and Oncology, Goethe-University Frankfurt, Frankfurt, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Partner Site Frankfurt a. M., Goethe-University Frankfurt, Frankfurt, Germany; Frankfurt Cancer Institute (FCI), Goethe-University Frankfurt, Frankfurt, Germany., Ghanaati S; Department of Oral, Maxillofacial and Facial Plastic Surgery, Goethe-University Frankfurt, Frankfurt, Germany.
Source: Oral oncology [Oral Oncol] 2025 May; Vol. 164, pp. 107252. Date of Electronic Publication: 2025 Mar 26.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier Country of Publication: England NLM ID: 9709118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1879-0593 (Electronic) Linking ISSN: 13688375 NLM ISO Abbreviation: Oral Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1879-0593
DOI:10.1016/j.oraloncology.2025.107252